Emergent BioSolutions EBS Earnings Call Transcripts

NYSE EBS
$6.01 -0.09 (-1.48%)
As of: Nov 10, 2026 · 10:26 AM EST
25 earnings calls on file for Emergent BioSolutions, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Emergent BioSolutions Q3 2026 Earnings Call

Nov 2, 2026 4,545 words · 20 min read
  • Joseph Papa.President and Chief Executive Officer
  • Richard Lindahl.Executive Vice President and Chief Financial Officer
  • Frank Vargo.Vice President and Treasurer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Emergent BioSolutions Earnings Call Transcripts

Calls25
LatestNov 2, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 25 Emergent BioSolutions transcripts Register to get access to Emergent BioSolutions’s earnings call transcripts.